Skip to Main Navigation

Indonesia Emergency Response to COVID-19 Additional Financing

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Indonesia.

Key Details

Project Details

  • P175759

  • Active

  • Pandu Harimurti , Somil Nagpal

  • Republic of Indonesia,Republic of Indonesia

  • Indonesia

  • November 20, 2020

  • (as of board presentation)

    June 17, 2021

  • N/A

  • US$ 8200.00 million

  • Ministry of Health,Ministry of Health

  • East Asia and Pacific

  • 2021

  • US$ 1244.90 million

  • N/A

  • N/A

  • June 30, 2024

  • BANK APPROVED

  • P173843

  • October 16, 2023

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Asian Infrastructure Investment Bank 500.00
Asian Infrastructure Investment Bank 500.00
Borrower/Recipient 2455.10
Borrower/Recipient 2455.10
GERMANY: KREDITANSTALT FUR WIEDERAUFBAU (KFW) 235.00
GERMANY: KREDITANSTALT FUR WIEDERAUFBAU (KFW) 235.00
Indonesia Australia Bank Umbrella Fund 9.90
Indonesia Australia Bank Umbrella Fund 9.90
International Bank for Reconstruction and Development 500.00
International Bank for Reconstruction and Development 500.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 500.00
IDA Commitment N/A
IBRD + IDA Commitment 500.00
Lending Instrument
Grant Amount 744.90
Total Project Cost** 8200.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)

Footnotes

Ratings

IMPLEMENTATION RATINGS

No data available.

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of population vaccinated, which is included in the priority population targets defined in national plan (by gender)Value0.000.0037.00
    DateJanuary 1, 2021February 28, 2022December 31, 2022
    Comment
  • Number of times MOH counters COVID-19 related misinformation and posts on its websiteValue0.00532.00200.00
    DateFebruary 1, 2020October 30, 2020March 31, 2021
    Comment
  • Cumulative number of website visitors to the COVID-19 communication portal set up by the Government of IndonesiaValue0.00311979.00100000.00
    DateFebruary 1, 2020October 30, 2020March 31, 2021
    Comment
  • MOH supports the creation of a multi-sectoral coordination mechanism for COVID-19 responseValueA multi-sectoral coordination mechanism for COVID-The multi-sectoral coordination mechanism for COVIThe multi-sectoral coordination mechanism for COVI
    DateMarch 1, 2020March 13, 2020September 30, 2020
    Comment
  • A surveillance mechanism for community-based reporting of outbreaks and new illnesses among humans and animals is functionalValueBaseline situation- no changeIn progressIntegration of different information sources to pr
    DateApril 1, 2020August 14, 2020June 30, 2021
    Comment
  • Cumulative number of COVID-19 suspect cases tested by PCR or rapid molecular testing, disaggregated by sexValue10000.004912745.00300000.00
    DateApril 1, 2020December 31, 2020November 30, 2020
    Comment
  • Infection prevention and clinical management protocols developed and disseminated to all non-referral facilitiesValueInfection prevention and clinical management protoMoH has issued the 5th revision of Guidelines for Infection prevention and clinical management proto
    DateMarch 1, 2020July 13, 2020December 31, 2020
    Comment
  • Number of COVID-19 cases successfully treated, disaggregated by sexValue0.00611097.0025000.00
    DateMarch 1, 2020December 31, 2020January 29, 2021
    Comment
  • Number of beds temporarily converted for patient isolation and/or low intensity medical careValue0.006011.001500.00
    DateApril 1, 2020December 31, 2020December 31, 2020
    Comment
  • Concrete measures to support and compensate health professionals for added COVID-19 related workload and risk are implementedValueConcrete measures to support and compensate healthIncentives and death compensation for health profeConcrete measures to support and compensate health
    DateApril 1, 2020June 30, 2020December 31, 2020
    Comment
  • Enhanced community engagement and communication (as measured by the number of interactions with the COVID-19 phone line)Value0.0016919.0025000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Improved reporting and surveillance system (measured as the availability of an improved surveillance system that incorporates lessons from the COVID-19 response experience)ValueNoneNoneImproved surveillance system available.
    DateApril 1, 2020December 31, 2020December 31, 2022
    Comment
  • Strengthened laboratory capacity (measured as total capacity for quality assured tests per day)Value3000.0070000.0090000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Reduced service readiness gap in treating severe respiratory illness patients (as measured by the available number of intensive care beds equipped as per national protocol)Value0.003974.006000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Percentage of population vaccinated, which is included in the priority population targets defined in national plan (by gender)Value0.000.0037.00
    DateJanuary 1, 2021February 28, 2022December 31, 2022
    Comment
  • Number of times MOH counters COVID-19 related misinformation and posts on its websiteValue0.00532.00200.00
    DateFebruary 1, 2020October 30, 2020March 31, 2021
    Comment
  • Cumulative number of website visitors to the COVID-19 communication portal set up by the Government of IndonesiaValue0.00311979.00100000.00
    DateFebruary 1, 2020October 30, 2020March 31, 2021
    Comment
  • MOH supports the creation of a multi-sectoral coordination mechanism for COVID-19 responseValueA multi-sectoral coordination mechanism for COVID-The multi-sectoral coordination mechanism for COVIThe multi-sectoral coordination mechanism for COVI
    DateMarch 1, 2020March 13, 2020September 30, 2020
    Comment
  • A surveillance mechanism for community-based reporting of outbreaks and new illnesses among humans and animals is functionalValueBaseline situation- no changeIn progressIntegration of different information sources to pr
    DateApril 1, 2020August 14, 2020June 30, 2021
    Comment
  • Cumulative number of COVID-19 suspect cases tested by PCR or rapid molecular testing, disaggregated by sexValue10000.004912745.00300000.00
    DateApril 1, 2020December 31, 2020November 30, 2020
    Comment
  • Infection prevention and clinical management protocols developed and disseminated to all non-referral facilitiesValueInfection prevention and clinical management protoMoH has issued the 5th revision of Guidelines for Infection prevention and clinical management proto
    DateMarch 1, 2020July 13, 2020December 31, 2020
    Comment
  • Number of COVID-19 cases successfully treated, disaggregated by sexValue0.00611097.0025000.00
    DateMarch 1, 2020December 31, 2020January 29, 2021
    Comment
  • Number of beds temporarily converted for patient isolation and/or low intensity medical careValue0.006011.001500.00
    DateApril 1, 2020December 31, 2020December 31, 2020
    Comment
  • Concrete measures to support and compensate health professionals for added COVID-19 related workload and risk are implementedValueConcrete measures to support and compensate healthIncentives and death compensation for health profeConcrete measures to support and compensate health
    DateApril 1, 2020June 30, 2020December 31, 2020
    Comment
  • Enhanced community engagement and communication (as measured by the number of interactions with the COVID-19 phone line)Value0.0016919.0025000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Improved reporting and surveillance system (measured as the availability of an improved surveillance system that incorporates lessons from the COVID-19 response experience)ValueNoneNoneImproved surveillance system available.
    DateApril 1, 2020December 31, 2020December 31, 2022
    Comment
  • Strengthened laboratory capacity (measured as total capacity for quality assured tests per day)Value3000.0070000.0090000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Reduced service readiness gap in treating severe respiratory illness patients (as measured by the available number of intensive care beds equipped as per national protocol)Value0.003974.006000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • MOH supports the creation of a multi-sectoral coordination mechanism for COVID-19 responseValueNoYesYes
    DateMarch 1, 2020March 13, 2020October 31, 2021
    Comment
  • Cumulative number of COVID-19 suspect cases tested by PCR or rapid molecular testing, disaggregated by sexValue10000.004912745.007000000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Concrete measures to support and compensate health professionals for added COVID-19 related workload and risk are implementedValueNoYesYes
    DateApril 1, 2020June 30, 2020October 31, 2021
    Comment
  • Number of beds temporarily converted for patient isolation and/or low intensity medical careValue0.006011.006011.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • A surveillance mechanism for community-based reporting of outbreaks and new illnesses among humans and animals is functionalValueNoNoYes
    DateApril 1, 2020October 30, 2020October 31, 2021
    Comment
  • Cumulative number of website visitors to the COVID-19 communication portal set up by the Government of IndonesiaValue5000.00311979.00750000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Number of COVID-19 cases successfully treated, disaggregated by sexValue0.00611097.001800000.00
    DateMarch 1, 2020February 28, 2021December 31, 2022
    Comment
  • Cumulative number of cases MOH counters COVID-19 vaccine related misinformation and posts on its websiteValue25.00532.00532.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Number of simulation exercises undertaken as per updated national pandemic preparedness planValue0.000.002.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Infection prevention and clinical management protocols developed and disseminated to all non-referral facilitiesValueNoYesYes
    DateApril 1, 2020July 13, 2020October 31, 2021
    Comment
  • Maintaining essential non COVID-19 services (% decline of number of completed fourth ANC services delivered in the previous quarteras a proportion to the corresponding quarter in 2019)Value88.50%88.50%At least 81.25%
    DateDecember 31, 2020February 28, 2021December 31, 2022
    Comment
  • Number of functional locations with remote temperature monitoring systemValue0.000.002400.00
    DateJune 30, 2020February 28, 2021December 31, 2022
    Comment
  • Pharmacovigilance system to monitor any adverse events related to COVID-19 vaccines is functional and producing reports.ValueA pharmacovigilance system is being established.A pharmacovigilance system is being established.A pharmacovigilance system is fully functional and
    DateApril 30, 2021February 28, 2021December 31, 2022
    Comment
  • MOH involved in the multi sector effort to monitor and counter measure misinformation about COVID-19 VaccinesValueNoNoYes
    DateFebruary 26, 2021May 5, 2021March 31, 2022
    Comment
  • MOH supports the creation of a multi-sectoral coordination mechanism for COVID-19 responseValueNoYesYes
    DateMarch 1, 2020March 13, 2020October 31, 2021
    Comment
  • Cumulative number of COVID-19 suspect cases tested by PCR or rapid molecular testing, disaggregated by sexValue10000.004912745.007000000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Concrete measures to support and compensate health professionals for added COVID-19 related workload and risk are implementedValueNoYesYes
    DateApril 1, 2020June 30, 2020October 31, 2021
    Comment
  • Number of beds temporarily converted for patient isolation and/or low intensity medical careValue0.006011.006011.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • A surveillance mechanism for community-based reporting of outbreaks and new illnesses among humans and animals is functionalValueNoNoYes
    DateApril 1, 2020October 30, 2020October 31, 2021
    Comment
  • Cumulative number of website visitors to the COVID-19 communication portal set up by the Government of IndonesiaValue5000.00311979.00750000.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Number of COVID-19 cases successfully treated, disaggregated by sexValue0.00611097.001800000.00
    DateMarch 1, 2020February 28, 2021December 31, 2022
    Comment
  • Cumulative number of cases MOH counters COVID-19 vaccine related misinformation and posts on its websiteValue25.00532.00532.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Number of simulation exercises undertaken as per updated national pandemic preparedness planValue0.000.002.00
    DateApril 1, 2020February 28, 2021December 31, 2022
    Comment
  • Infection prevention and clinical management protocols developed and disseminated to all non-referral facilitiesValueNoYesYes
    DateApril 1, 2020July 13, 2020October 31, 2021
    Comment
  • Maintaining essential non COVID-19 services (% decline of number of completed fourth ANC services delivered in the previous quarteras a proportion to the corresponding quarter in 2019)Value88.50%88.50%At least 81.25%
    DateDecember 31, 2020February 28, 2021December 31, 2022
    Comment
  • Number of functional locations with remote temperature monitoring systemValue0.000.002400.00
    DateJune 30, 2020February 28, 2021December 31, 2022
    Comment
  • Pharmacovigilance system to monitor any adverse events related to COVID-19 vaccines is functional and producing reports.ValueA pharmacovigilance system is being established.A pharmacovigilance system is being established.A pharmacovigilance system is fully functional and
    DateApril 30, 2021February 28, 2021December 31, 2022
    Comment
  • MOH involved in the multi sector effort to monitor and counter measure misinformation about COVID-19 VaccinesValueNoNoYes
    DateFebruary 26, 2021May 5, 2021March 31, 2022
    Comment